SCHEMBL1445286

SCHEMBL1445286

NC(=O)c1ccc(-c2ccncn2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 2/20 0.54
CYP17A1 P05093 1/20 0.51
MKNK1 Q9BUB5 7/20 0.49
MKNK2 Q9HBH9 7/20 0.49
CHEK2 O96017 2/20 0.47
CYP2D6 P10635 2/20 0.45
MAPK8 P45983 1/20 0.44
MAPK10 P53779 1/20 0.44
ROCK1 Q13464 2/20 0.43
MAPK1 P28482 2/20 0.43
ROCK2 O75116 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
PRKCG P05129 1/20 0.43
PRKACA P17612 1/20 0.43
RPS6KB1 P23443 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
PRKX P51817 1/20 0.43
PRKCD Q05655 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4772421 0.84 CAMK2D (0.54) MKNK1MKNK2CYP2D6ROCK1MAPK1
SCHEMBL6306083 0.82 CYP2D6 (0.45) MAP4K4CYP2D6MAPK10ROCK1MAPK1
SCHEMBL1445168 0.81 FYN (0.52) MAPK1GSK3BFYN
SCHEMBL9903935 0.80 CYP2D6 (0.60) MAP4K4CYP2D6MAPK10ROCK1MAPK1
SCHEMBL5270117 0.79 NNMT (0.43) MAP4K4CYP17A1MKNK1MKNK2CHEK2
SCHEMBL27913276 0.78 CYP2D6 (0.53) CYP2D6ROCK1MAPK1ROCK2CYP3A4
SCHEMBL29138051 0.78 AR (0.41) MAP4K4CYP17A1MKNK1MKNK2CHEK2
SCHEMBL28103664 0.78 CA2 (0.46) CYP17A1CYP2D6
SCHEMBL6299308 0.78 ALDH1A1 (0.53) CYP2D6ROCK1MAPK1ROCK2CYP3A4
SCHEMBL3104632 0.77 CYP17A1 (0.72) MAP4K4CYP17A1MKNK1MKNK2CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2480235-A2 NOVEL IODO PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF)-IMPLICATED DISEASES AND CONDITIONS University Of Louisville Research Foundation, Inc. (US) 2012-08-01 EP claimed
WO-2011038234-A2 NOVEL IODO PYRIMIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF)-IMPLICATED DISEASES AND CONDITIONS UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) 2011-03-31 WO claimed
EP-2193119-B1 4-(4-PYRIDINYL)-BENZAMIDES AND THEIR USE AS ROCK ACTIVITY MODULATORS ABBVIE DEUTSCHLAND (DE) 2014-01-01 EP disclosed
EP-2193119-A1 4-(4-PYRIDINYL)-BENZAMIDES AND THEIR USE AS ROCK ACTIVITY MODULATORS Abbott GmbH & Co. KG (DE) 2010-06-09 EP disclosed
WO-2009027392-A1 4-(4-PYRIDINYL)-BENZAMIDES AND THEIR USE AS ROCK ACTIVITY MODULATORS ABBOTT GMBH & CO. KG (DE) 2009-03-05 WO disclosed